Beyond Antibiotics 2026 Grant Call

AMBER Tx OISI

Strategy Notes

Sector overlap in AMR but poor fit: grant emphasizes educational initiatives and preventive stewardship strategies to reduce antibiotic need, while venture focuses on computational drug resistance prediction via AI/ML. Venture is pre-seed biotech R&D; grant appears targeted at public health/education programs. Page does not disclose funding amount, deadline, or geographic eligibility.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: —
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-09 OPEN → INELIGIBLE · The 2026 call has a single, exclusive thematic scope — 'Preventive Strategies That Lower the Need for Antibiotic Use' (AMR infection prevention and antibiotic stewardship). The applicant's entire portfolio — the CCT addiction model, IMPRINT (addiction-liability screening), TOPOLOGIX (hERG cardiotoxicity / drug-protein TDA), and GATE (BCI safety) — operates in addiction neuropharmacology and computational pharmacology with no direct connection to antimicrobial resistance, infection prevention, or antibiotic use reduction. There is no component of the current work that maps to the stated 2026 theme.